Literature DB >> 9581694

Persistent viremia after recovery from self-limited acute hepatitis B.

H Yotsuyanagi1, K Yasuda, S Iino, K Moriya, Y Shintani, H Fujie, T Tsutsumi, S Kimura, K Koike.   

Abstract

To define the duration of viremia in the course of acute hepatitis B, we semiquantitatively determined the levels of hepatitis B virus (HBV) DNA in the sera, using polymerase chain reaction (PCR) coupled with Southern blotting, of non-immunocompromised patients with self-limited acute hepatitis B. In the sera of 10 of 11 patients, HBV DNA, which was presumably coated with viral proteins, was detected for a long period after recovery, even at the final observation times, which ranged from 6 to 19 months after disease onset. To characterize the mode of HBV that was present in serum, we immunoprecipitated immune complexes in sera by the addition of anti-human immunoglobulin G (IgG) and determined the levels of HBV DNA separately in the supernatants and pellets. In the acute phase of hepatitis B, high levels of HBV DNA were detected both in the supernatants and pellets at comparative levels. After the convalescent phase, the amount of HBV DNA in the supernatant decreased with respect to that in the pellets. It is notable that, in most cases, serum HBV persisted as a form of immune complex even after the seroconversion to antibody to hepatitis B surface antigen (anti-HBs). These data suggest that the replication of HBV may persist in some organs, most likely in the liver or peripheral blood cells, for a long period after recovery from acute hepatitis B, and the data indicate the possible transmission of HBV from organ transplantation donors who exhibit serological markers of past infection only.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581694     DOI: 10.1002/hep.510270526

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  35 in total

Review 1.  Occult hepatitis B: clinical implications and treatment decisions.

Authors:  Paul Schmeltzer; Kenneth E Sherman
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

2.  Identification of different states of hepatitis B virus infection with a quantitative PCR assay.

Authors:  H H Kessler; S Preininger; E Stelzl; E Daghofer; B I Santner; E Marth; H Lackner; R E Stauber
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 3.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  Hepatitis B virus reactivation in a patient with chronic GVHD after allogeneic peripheral blood stem cell transplantation.

Authors:  H Sakamaki; Y Sato; S I Mori; K Ohashi; S Tanikawa; H Akiyama; T Sasaki; K Hiruma
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

5.  Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus.

Authors:  Haruki Komatsu; Ayano Inui; Tsuyoshi Sogo; Eitaro Hiejima; Akihiko Tateno; Paul Klenerman; Tomoo Fujisawa
Journal:  BMC Infect Dis       Date:  2010-04-28       Impact factor: 3.090

6.  A mutation of the start codon in the X region of hepatitis B virus DNA in a patient with non-B, non-C chronic hepatitis.

Authors:  Kiyotaka Fujise; Keiko Tatsuzawa; Midori Kono; Sadayori Hoshina; Akihito Tsubota; Minoru Niiya; Yoshihisa Namiki; Norio Tada; Hisao Tajiri
Journal:  World J Hepatol       Date:  2011-02-27

7.  Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.

Authors:  Swati Gupta; Sarman Singh
Journal:  BMC Infect Dis       Date:  2010-03-07       Impact factor: 3.090

8.  Molecular characteristics of occult hepatitis B virus from blood donors in southeast China.

Authors:  Quan Yuan; Shan-Hai Ou; Chang-Rong Chen; Sheng-Xiang Ge; Bin Pei; Qing-Rui Chen; Qiang Yan; Yong-Cai Lin; Hong-Ying Ni; Cheng-Hao Huang; Anthony E T Yeo; James W K Shih; Jun Zhang; Ning-Shao Xia
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

9.  Hepatitis B: the virus and disease.

Authors:  T Jake Liang
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

10.  Repeated passage of wild-type woodchuck hepatitis virus in lymphoid cells does not generate cell type-specific variants or alter virus infectivity.

Authors:  Patricia M Mulrooney-Cousins; Tomasz I Michalak
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.